Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Epidemiology  of CTO. Why are data different? Vladimir Ganyukov MD, PhD State Research Institute for Complex Issues of Car...
The real prevalence of CTOs is unknown!
Why are data different? <ul><li>Genetic predisposition to atherosclerosis; </li></ul><ul><li>National dietary habits; </li...
CTO prevalence  <ul><li>~ 20-40% angiographically documented CAD; </li></ul><ul><li>~10% of targets for PCI. </li></ul>
Christofferson R.D., Lehmann K.G., Martin G.V. et al.  Effect of Chronic Total Coronary Occlusion on Treatment Strategy.  ...
TCT2011
TCT2011
TCT2011
TCT2011
TCT2011
TCT2011
TCT2011 2006 Germany experience = 7,6% CTO recanalisation of elective PCI
 
2011 State Research Institute for Complex Issues of Cardiovascular Diseases, KEMEROVO, RUSSIAN FEDERATION 887 (21.4%) 4146...
2011 State Research Institute for Complex Issues of Cardiovascular Diseases, KEMEROVO, RUSSIAN FEDERATION 1172 elective PC...
Conclusions <ul><li>CTO prevalence is high  in any communi ty . </li></ul><ul><li>The national differences of CTO prevalen...
Upcoming SlideShare
Loading in …5
×

В.А. Ганюков "Эпидемиология хронических окклюзий коронарных артерий. Почему данные разнятся?"

846 views

Published on

Published in: Health & Medicine, Technology
  • Be the first to comment

  • Be the first to like this

В.А. Ганюков "Эпидемиология хронических окклюзий коронарных артерий. Почему данные разнятся?"

  1. 1. Epidemiology of CTO. Why are data different? Vladimir Ganyukov MD, PhD State Research Institute for Complex Issues of Cardiovascular Diseases, KEMEROVO, RUSSIAN FEDERATION
  2. 2. The real prevalence of CTOs is unknown!
  3. 3. Why are data different? <ul><li>Genetic predisposition to atherosclerosis; </li></ul><ul><li>National dietary habits; </li></ul><ul><li>Smoking prevalence; </li></ul><ul><li>Access to PPCI . </li></ul>
  4. 4. CTO prevalence <ul><li>~ 20-40% angiographically documented CAD; </li></ul><ul><li>~10% of targets for PCI. </li></ul>
  5. 5. Christofferson R.D., Lehmann K.G., Martin G.V. et al. Effect of Chronic Total Coronary Occlusion on Treatment Strategy. //Am. J. Cardiol. – 2005. – Vol. 9 5. - P. 1088-1091. <ul><li>8,004 consecutive diagnostic catheterization at a single с entre ; </li></ul><ul><li>CTO was found in 24% of all patients; </li></ul><ul><li>CTO was found in 52% of patients with significant (≥70% diameter stenosis) coronary artery disease. </li></ul>
  6. 6. TCT2011
  7. 7. TCT2011
  8. 8. TCT2011
  9. 9. TCT2011
  10. 10. TCT2011
  11. 11. TCT2011
  12. 12. TCT2011 2006 Germany experience = 7,6% CTO recanalisation of elective PCI
  13. 14. 2011 State Research Institute for Complex Issues of Cardiovascular Diseases, KEMEROVO, RUSSIAN FEDERATION 887 (21.4%) 4146 elective coronary angios 306 (3 5 %) 214 (24%) 367 (41%)
  14. 15. 2011 State Research Institute for Complex Issues of Cardiovascular Diseases, KEMEROVO, RUSSIAN FEDERATION 1172 elective PCI Attempted CTO PCI n=170 (14.5%) Successful CTO PCI n=127 (10.8%) Selected for CTO PCI n=214 (18.3%)
  15. 16. Conclusions <ul><li>CTO prevalence is high in any communi ty . </li></ul><ul><li>The national differences of CTO prevalence may be associated with: </li></ul><ul><li>a genetic predisposition to atherosclerosis, </li></ul><ul><li>national dietary habits, </li></ul><ul><li>smoking prevalence and </li></ul><ul><li>access to primary PCI. </li></ul><ul><li>3. It is important to know the prevalence of these factors for each region to choose the right way of modification. </li></ul>

×